← Back to Search

Behavioural Intervention

SurePace Powered Walker User for Cerebral Palsy

N/A

Waitlist Available

Led By Jason Burkholder, Ph.D.

Research Sponsored by Barron Associates, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up five minutes

Awards & highlights

Study Summary

This trial is testing a computer-driven walker that will help people with walking disabilities by reducing the amount of energy needed to walk.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ five minutes

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~five minutes

This trial's timeline: 3 weeks for screening, Varies for treatment, and five minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Metabolic Cost (oxygen consumption)

Trial Design

1Treatment groups

Experimental Treatment

Group I: SurePace Powered Walker UserExperimental Treatment1 Intervention

Before any formal experiments are conducted, participants will be given an opportunity to "train" with the new powered walker for a pre-defined period of time to eliminate the confounding effects of being unfamiliar with using the device. (See the description of UVA's facilities and Protection of Human Subjects document for additional discussion of safety measures/protocols and Institutional Review Board procedures.) Experiments will consist of one-hour sessions (with adequate rest periods between trials and time for evaluations) in which participants will be asked to walk at a self-selected (comfortable) walking speed through a pre-defined 8 m x 4 m oval course.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

SurePace Powered Walker User

2020

N/A

~50

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Barron Associates, Inc.Lead Sponsor

6 Previous Clinical Trials

186 Total Patients Enrolled

University of VirginiaOTHER

753 Previous Clinical Trials

1,244,983 Total Patients Enrolled

5 Trials studying Cerebral Palsy

516 Patients Enrolled for Cerebral Palsy

National Institutes of Health (NIH)NIH

2,696 Previous Clinical Trials

6,952,540 Total Patients Enrolled

7 Trials studying Cerebral Palsy

1,025 Patients Enrolled for Cerebral Palsy

Media Library

Intelligent and Adaptive Control (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05465239 — N/A

Cerebral Palsy Research Study Groups: SurePace Powered Walker User

Cerebral Palsy Clinical Trial 2023: Intelligent and Adaptive Control Highlights & Side Effects. Trial Name: NCT05465239 — N/A

Intelligent and Adaptive Control (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05465239 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can individuals of advanced age participate in this trial?

"To take part in this medical trial, patients must be aged 6 to 75. Additionally, there are 140 studies for minors and 26 for the elderly population."

Answered by AI

Are there any current opportunities for participation in this research project?

"Affirmative. Clinicaltrials.gov data reveals that this clinical trial, first published on September 1st 2020, is actively recruiting patients. The hunt for the necessary 60 participants will take place at a single location."

Answered by AI

How many participants are currently engaged in this trial?

"Affirmative, the information on clinicaltrials.gov suggests that this trial is actively recruiting participants. It was first published on September 1st 2020 and has since been updated for the final time on July 26th 2022. Sixty patients need to be enrolled from a single medical centre."

Answered by AI

Is it possible for me to participate in this medical experiment?

"This trial, which seeks to recruit sixty cerebral palsy patients aged between 6 and 75 years old, necessitates that participants meet a number of prerequisites; these include the ability to ambulate 40ft without aid (except for walking aids), GMFCS level II-III, an absence of surgeries in the past six months, proficiency in understanding and following commands, spastic CP diagnosis and being within the age range 5-25."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Intelligent and Adaptive Control Applied to Powered Walkers

2020. "Intelligent and Adaptive Control Applied to Powered Walkers". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05465239.